NOS Activators

Featured Inhibitors
Inhibitors (23)
Modulator (1)
Chemicals (2)
Agonist (1)
Activators (2)

Cat.No.	Product Name	Information	Product Use Citations	Product Validations
S3589	Bendazol	Bendazol (2-Benzylbenzimidazole, Dibazol, Dibazole, Bendazole, Tromasedan) is a hypotensive drug that enhances NO synthase activity in renal glomeruli and collecting tubules. This compound inhibits the progression of form-deprivation myopia (FDM) and suppresses the upregulation of HIF-1α.
S2979	CU-T12-9	CU-T12-9 is a specific agonist of Toll-like receptor (TLR) 1/2 with EC50 of 52.9 nM in HEK-Blue hTLR2 SEAP assay. This compound activates both the innate and the adaptive immune systems. It signals through NF-κB and invokes an elevation of the downstream effectors TNF-α, IL-10, and iNOS.	Nat Commun, 2025, 16(1):2743 Biomedicine & Pharmacotherapy, 2023, 114638 Biomed Pharmacother, 2023, 162:114638

Cat.No.

Product Name

Information

Product Use Citations

Product Validations

S3589

Bendazol

Bendazol (2-Benzylbenzimidazole, Dibazol, Dibazole, Bendazole, Tromasedan) is a hypotensive drug that enhances NO synthase activity in renal glomeruli and collecting tubules. This compound inhibits the progression of form-deprivation myopia (FDM) and suppresses the upregulation of HIF-1α.

S2979

CU-T12-9

CU-T12-9 is a specific agonist of Toll-like receptor (TLR) 1/2 with EC50 of 52.9 nM in HEK-Blue hTLR2 SEAP assay. This compound activates both the innate and the adaptive immune systems. It signals through NF-κB and invokes an elevation of the downstream effectors TNF-α, IL-10, and iNOS.

Nat Commun, 2025, 16(1):2743

Biomedicine & Pharmacotherapy, 2023, 114638

Biomed Pharmacother, 2023, 162:114638